Crystalline salts of a t-type calcium channel modulator and methods of use thereof
AssigneePraxis Precision Medicines, Inc.
InventorsDaniel Thomas Walters, Thomas San Ie
Life of this patent
Estimating the term…
Abstract
The present disclosure provides Pattern D, i.e., a crystalline form of N-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide hydrochloride salt trihydrate (Compound 1). The present disclosure also provides pharmaceutical compositions comprising Compound 1 in the form of Pattern D, as well as methods of treating neurological and psychiatric disorders by administering to a subject in need thereof Compound 1 in the form of Pattern D or a pharmaceutical composition comprising Compound 1 in the form of Pattern D.
Claims19
A crystalline form of N-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide hydrochloride salt trihydrate (Compound 1) characterized by an x-ray powder diffraction (XRPD) pattern comprising at least one peak at the diffraction angle (° 2θ) selected from the group consisting of:
- a peak at approximately 12.0°;
- a peak at approximately 15.6°;
- a peak at approximately 16.7°;
- a peak at approximately 19.8°;
- a peak at approximately 21.2°;
- a peak at approximately 24.1°;
- a peak at approximately 25.2°;
- a peak at approximately 27.3°;
- and
- a peak at approximately 30.2°.
Dependencies are inferred from the claim text.